Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

145 results about "Tissue necrosis" patented technology

Necrosis. Necrosis is the death of body tissue. It occurs when too little blood flows to the tissue. This can be from injury, radiation, or chemicals. Necrosis cannot be reversed. When large areas of tissue die due to a lack of blood supply, the condition is called gangrene.

Implantable device for penetrating and delivering agents to cardiac tissue

An implantable devices for the effective elimination of an arrhythmogenic site from the myocardium is presented. By inserting small biocompatible conductors and/or insulators into the heart tissue at the arrhythmogenic site, it is possible to effectively eliminate a portion of the tissue from the electric field and current paths within the heart. The device would act as an alternative to the standard techniques for the removal of tissue from the effective contribution to the hearts electrical action which require the destruction of tissue via energy transfer (RF, microwave, cryogenic, etc.). This device is a significant improvement in the state of the art in that it does not require tissue necrosis.In one preferred embodiment the device is a non conductive helix that is permanently implanted into the heart wall around the arrhythmogenic site. In variations on the embodiment, the structure is wholly or partially conductive, the structure is used as an implantable substrate for anti arrhythmic, inflammatory, or angiogenic pharmacological agents, and the structure is deliverable by a catheter with a disengaging stylet. In other preferred embodiments that may incorporate the same variations, the device is a straight or curved stake, or a group of such stakes that are inserted simultaneously.
Owner:BIOCARDIA

Method for reducing human body fat and weight reducing instrument adopting method

ActiveCN102319141BAvoid necrosis and other injuriesLight therapyTherapeutic coolingEngineeringFat reduction
A fat-reduction weight-loss method, comprising: firstly, locally heating a site in need of fat-reduction under 37 to 60°C until the blood and muscles separate from the fat; then, locally freezing the site in need of fat-reduction under -10 to 5°C until the fat solidifies. Also disclosed is a weight-loss instrument using the fat-reduction weight-loss method, comprising: an input unit (A) for receiving a user operation and outputting a signal representing the user operation to a control unit (B); a control unit (B) for outputting a heating signal or a freezing signal to a heating and freezing unit (C) according to the received signal representing the user operation; and a heating and freezing unit (C) for receiving the heating signal or freezing signal of the control unit (B) and conducting the heating or freezing operation. The fat-reduction weight-loss method at first locally heats the site in need of fat-reduction to separate the blood and muscles from the fat at the site in need of fat-reduction, then instantaneously freezes the site in need of fat-reduction to solidify the fat, thus avoiding the harms such as tissue necrosis and the like caused by the solidification of the blood and muscles together with the fat in the freezing fat-reduction process.
Owner:GUANGZHOU BECO ELECTRONICS TECH

Prevention of tissue ischemia, related methods and compositions

Provided herein are compositions and methods for preventing, ameliorating, and / or reducing tissue ischemia and / or tissue damage due to ischemia, increasing blood vessel diameter, blood flow and tissue perfusion in the presence of vascular disease including peripheral vascular disease, atherosclerotic vascular disease, coronary artery disease, stroke and influencing other conditions, by suppressing CD47 and / or blocking TSP1 and / or CD47 activity or interaction. Influencing the interaction of CD47-TSP1 in blood vessels allows for control of blood vessel diameter and blood flow, and permits modification of blood pressure and cardiac function. Under conditions of decreased blood flow, for instance through injury or atherosclerosis, blocking TSP1-CD47 interaction allows blood vessels to dilate and increases blood flow, tissue perfusion and tissue survival. This in turn reduces or prevents tissue necrosis and death. The therapeutics identified herein allow for precise regulation of blood flow to tissues and organs which need it, while substantially avoiding systemic complications. Methods and compositions described herein can be used to increase tissue survival under conditions of trauma and surgery, as well as conditions of chronic vascular disease. Also disclosed are methods for the treatment of elderly subjects using agents that affect TSP1 and CD47 and thereby affect tissue perfusion. Additionally, provided herein are compositions and methods for influencing blood coagulation, allowing for controlled increased or decreased blood clotting. Additionally, provided herein are compositions and methods for decreasing blood flow, as in the case of cancer through mimicking the effects of TSP1 and CD47 on blood vessel diameter and blood flow.
Owner:WASHINGTON UNIV IN SAINT LOUIS +1

Leg reciprocating massaging wheel chair for nursing department

The invention discloses a leg reciprocating massaging wheel chair for a nursing department. The leg reciprocating massaging wheel chair comprises a base plate. The wheel chair is characterized in that a back plate is fixedly connected to the right side of the base plate, driving wheels are rotatably connected to the lower portion of the back plate, a motor base is fixedly connected to the middle of the base plate, a motor is fixedly connected to the position over the motor base, and a first sheave wheel is fixedly connected to the output end of the motor; a seat plate is fixedly connected to the left side of the back plate, the lower end of the seat plate is fixedly connected with the base plate, a first through groove is formed in the left side of the seat plate, and a massaging device is fixedly connected below the seat plate; a longitudinal rotating shaft is rotatably connected to the middle of the base plate. Compared with the prior art, the wheel chair has the advantages that the structure is simple, the cruising ability of a patient sitting on the wheel chair is greatly increased through electric drive, and the patient can move to a farther place; in addition, the massage device can be controlled to massage the leg of the patient, leg rehabilitation of the patient is promoted, and leg tissue necrosis of the patient can be effectively avoided.
Owner:佛山市丰和医疗科技有限公司

Modeling method of necrosis caput femoris restoring model based on umbrella-shaped caput femoris supporter

The invention discloses a modeling method of a necrosis caput femoris restoring model based on an umbrella-shaped caput femoris supporter. The modeling method comprises the steps that firstly, a three-dimensional model of a to-be-restored caput femoris is obtained, wherein the NURBS curved surface model of the to-be-restored caput femoris is obtained, the to-be-restored caput femoris is a caput femoris which exists in the thigh tissue necrosis area and is pre-restored by the caput femoris supporter, and the caput femoris supporter is composed of an umbrella-shaped supporter body and a supporting sleeve; secondly, the necrosis area needing to be separated is determined according to the shape of the umbrella-shaped supporter body, and a necrosis caput femoris model is established; thirdly, a caput femoris supporter model is established; fourthly, a necrosis caput femoris implantation model is established, wherein the necrosis caput femoris implantation model with an implantation channel and a three-dimensional model of an implanted bone are established; fifthly, the necrosis caput femoris restoring model is established. The modeling method is simple in step, reasonable in design, convenient to achieve and good in using effect, the restoring model of the caput femoris supporter implanted into the necrosis caput femoris can be easily, conveniently and quickly established, and the quality of the established restoring model is high.
Owner:XIAN UNIV OF SCI & TECH

Pneumatic automatic hemostasis equipment and pneumatic automatic hemostasis method

The invention discloses pneumatic automatic hemostasis equipment and a pneumatic automatic hemostasis method. The method includes the steps of starting a timer to compute hemostasis time of a tourniquet acting on a wound surface; controlling a miniature air pump to suck in air via air inlet holes to inflate the tourniquet and acquiring an air pressure value in the tourniquet by an air pressure sensor; when the air pressure value is smaller than a first preset value, continuing controlling the miniature air pump to suck in the air via the air inlet holes to inflate the tourniquet; when the air pressure value is larger than a second preset value, controlling the miniature air pump to deflate the tourniquet via air outlet holes; when the air pressure value is between the first preset value and the second preset value, judging whether the hemostasis time reaches preset time or not; when the hemostasis time reaches the preset time, controlling a loudspeaker to play voice information to inform medical personnel of checking hemostasis conditions of the wound surface. The pneumatic automatic hemostasis equipment and the pneumatic automatic hemostasis method have the advantages that the problems of poor hemostatic effects caused by too high or too low hemostasis pressure of the tourniquet acting on the wound surface and wound tissue necrosis caused by long-time continuous vascular compression can be avoided effectively.
Owner:SHENZHEN QIANHAI KANGQIYUAN TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products